Open access · CC-BY
via OpenAlex
Procyanidin C1 inhibits bleomycin‐induced pulmonary fibrosis in mice by selective clearance of senescent myofibroblasts
Min Shao, Yujia Qiu, Mengxia Shen, Wei Qing Liu, Dandan Feng, Ziqiang Luo, Yan Zhou
The FASEB Journal · 2024 · ▲ 21 citations
Cellular senescence
Altered intercellular communication
Senolytics
Cell culture / in vitro
Human
Mouse
Abstract
Pulmonary fibrosis is a formidable challenge in chronic and age-related lung diseases. Myofibroblasts secrete large amounts of extracellular matrix and induce pro-repair responses during normal wound healing. Successful tissue repair results in termination of myofibroblast activity via apoptosis; however, some myofibroblasts exhibit a senescent phenotype and escape apoptosis, causing over-repair that is characterized by pathological fibrotic scarring. Therefore, the removal of senescent myofibroblasts using senolytics(definition) is an important method for the treatment of pulmonary fibrosis. Procyanidin C1 (PCC1) has recently been discovered as a senolytic compound with very low toxicity and few side effects. This study aimed to determine whether PCC1 could improve lung fibrosis by promoting apoptosis in senescent myofibroblasts and to investigate the mechanisms involved. The results showed that PCC1 attenuates bleomycin (BLM)-induced pulmonary fibrosis in mice. In addition, we found that PCC1 inhibited extracellular matrix deposition and promoted the apoptosis of senescent myofibroblasts by increasing PUMA expression and activating the BAX signaling pathway. Our findings represent a new method of pulmonary fibrosis management and emphasize the potential of PCC1 as a senotherapeutic agent for the treatment of pulmonary fibrosis, providing hope for patients with pulmonary fibrosis worldwide. Our results advance our understanding of age-related diseases and highlight the importance of addressing cellular senescence(definition) in treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1096/fj.202302547rr
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Shao, M., Qiu, Y., Shen, M., Liu, W.Q., Feng, D., Luo, Z., & Zhou, Y. (2024). Procyanidin C1 inhibits bleomycin‐induced pulmonary fibrosis in mice by selective clearance of senescent myofibroblasts. <em>The FASEB Journal</em>. https://doi.org/10.1096/fj.202302547rr
Vancouver
Shao M, Qiu Y, Shen M, Liu WQ, Feng D, Luo Z, et al. Procyanidin C1 inhibits bleomycin‐induced pulmonary fibrosis in mice by selective clearance of senescent myofibroblasts. The FASEB Journal. 2024. doi:10.1096/fj.202302547rr.
BibTeX
@article{min2024Procya,
title = {Procyanidin C1 inhibits bleomycin‐induced pulmonary fibrosis in mice by selective clearance of senescent myofibroblasts},
author = {Min Shao and Yujia Qiu and Mengxia Shen and Wei Qing Liu and Dandan Feng and Ziqiang Luo and Yan Zhou},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202302547rr},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Respiratory Research 2016
Open access · CC-BY
Metformin attenuates lung fibrosis development via NOX4 suppression
Molecular Nutrition & Food Research 2017
Citation only
Resveratrol Ameliorates the Severity of Fibrogenesis in Mice with Experimental Chronic Pancreatitis
Experimental Gerontology 2020
Open access · CC-BY
Cell senescence and fibrotic lung diseases
npj Aging 2025
Open access · CC-BY
Senolytic effects of a modified Gingerenone A
PLoS ONE 2013
Open access · CC-BY
Cartilage Oligomeric Matrix Protein in Idiopathic Pulmonary Fibrosis
Stem Cell Research & Therapy 2020
Open access · CC-BY